(Q42607866)

3 November 2017

Putative anxiety-linked effects of the nitric oxide synthase inhibitor L-NAME in three murine exploratory behavior models (English)

1 reference

3 November 2017

Donald A Czech

1

1 reference

3 November 2017

Erika B Jacobson

series ordinal

2

1 reference

3 November 2017

Kolitta T LeSueur-Reed

series ordinal

3

1 reference

3 November 2017

Melanie R Kazel

series ordinal

4

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Pharmacology, Biochemistry and Behavior

3 November 2017

1 reference

3 November 2017

75

1 reference

3 November 2017

4

1 reference

3 November 2017

741-748

1 reference

Inhibition of nitric oxide synthesis with L-NAME suppresses isolation-induced ultrasounds in rat pups.

3 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Exploratory behavior models of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Gases as biological messengers: nitric oxide and carbon monoxide in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Effects of L-NOARG on plus-maze performance in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

The nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Factors controlling measures of anxiety and responses to novelty in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Validity of head-dipping as a measure of exploration in a modified hole-board

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Anxiolytic effect of nitric oxide synthase inhibitors microinjected into the dorsal central grey

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Central actions of nitric oxide in regulation of autonomic functions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Comparison of N2O- and chlordiazepoxide-induced behaviors in the light/dark exploration test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Effects of a nitric oxide donor on behavior and interaction with nitrous oxide in the mouse light/dark exploration test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Effects of centrally administered anxiolytic compounds in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Effects of nitric oxide on neuroendocrine function and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Inhibition of nitric oxide synthase reduces ultrasonic vocalizations of rat pups

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

The effects of the nitric oxide synthase inhibitors on the behaviour of small-platform-stressed mice in the plus-maze test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Nociception, pain, and antinociception: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Anxiety, defence and the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

The nitric oxide synthesis inhibitor L-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

Nitric oxide and substance dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900149-7

7 January 2021

10.1016/S0091-3057(03)00149-7

Identifiers

DOI

1 reference

release_uon5kfemcbhobhhm5lpdhgjttu

3 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uon5kfemcbhobhhm5lpdhgjttu

24 November 2022

mapped directly with Wikidata item

1 reference